Your new experience awaits. Try the new design now and help us make it even better

STUDY PROTOCOL article

Front. Endocrinol.

Sec. Translational and Clinical Endocrinology

This article is part of the Research TopicVibratory Therapy: Impacts on Endocrine DisordersView all 3 articles

Whole-body vibration training on functional capacity, vascular function, and glycemic control in type 2 diabetes individuals with peripheral arterial disease: protocol for a randomized clinical trial

Provisionally accepted
  • 1The University of Auckland, Auckland, New Zealand
  • 2Chiang Mai University, Chiang Mai, Thailand

The final, formatted version of the article will be published soon.

Background: Type 2 diabetes and peripheral arterial disease contribute to long-term disability. Walking-based exercise improves related symptoms, but adherence is limited by low fitness and leg pain. Whole body vibration stimulates muscle contractions and increases limb and microvascular blood flow which can mimic the impact of walking. Prior studies suggest improved endothelial function, reduced arterial stiffness, and lower glycated hemoglobin following vibration therapy, however its effects on functional capacity in this group remain unclear. Aims: To investigate whether whole body vibration impacts functional capacity achieved with supervised treadmill walking, as measured by incremental shuttle walk test distance with a pre specified non inferiority margin. Study design: Randomized clinical trial of 48 participants aged 50 years or older with ankle brachial index 0.9 or less or toe brachial index 0.7 or less and Fontaine stage I to IIb will be included. Participants will receive whole body vibration or supervised treadmill walking for 12 weeks, three sessions per week. Whole body vibration will be delivered using a Galileo plate. Analyses will follow intention to treat using a general linear model adjusted for age, sex, peripheral arterial disease category, diabetes duration, and baseline incremental shuttle walk test distance. Primary outcome: Distance in the incremental shuttle walks test. Secondary outcomes: Ankle brachial index, toe brachial index, brachial artery flow mediated dilation, glycated hemoglobin, SF-36 health related quality of life, and Peripheral Artery Questionnaire scores. Adverse events will be monitored. Implications for clinical practice: If efficacy is demonstrated, this intervention could serve as a clinic-based exercise option to improve mobility, vascular function, and glycemic control in this population. Trial registration: Thai Clinical Trials Registry - TCTR20251020003.

Keywords: Blood flow, Functional capacity (FC), PAD (peripheral arterial disease), type 2 diabetes, Vibration

Received: 28 Oct 2025; Accepted: 16 Jan 2026.

Copyright: © 2026 Gusso, Nantakool, Chuatrakoon and Derraik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Silmara Gusso

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.